Hazardous Surgical Smoke: Risk Assessment and Evaluation of a New Smoke Extractor System in the Surgical Unit

Sponsor
University Hospital Inselspital, Berne (Other)
Overall Status
Completed
CT.gov ID
NCT03924206
Collaborator
Tofwerk AG, Thun Switzerland (equipment, data analysis) (Other), Lungenliga Bern (main funding) (Other), Erbe Swiss AG (equipment) (Other)
142
1
3.9
36.3

Study Details

Study Description

Brief Summary

The investigators will define two separate groups of surgical procedures: 1.) an 'open group' in which mainly open anatomic lung resections will be included, and 2.) a 'minimally invasive' group in which mainly thoracoscopic anatomic lung resections will be included.

Both groups will then be randomized to either the performance of the surgical procedure under 'standard conditions' or to the performance of the procedure with the additional use of a smoke evacuation system.

During every procedure the hazardous smoke that is generated by the electrocautery in the surgical field will be collected through a tube at the height of the surgeons face. The smoke is then directly transferred to a mass spectrometer that is situated in the operating room (OR) and performs a real-time analysis of the chemical substances in the air. The degree of air pollution will be measured as well as the smoke evacuation systems' ability to reduce these hazardous chemical substances in the air can be evaluated.

Condition or Disease Intervention/Treatment Phase
  • Device: Smoke evacuation system

Detailed Description

Smoke samples will be continuously analyzed with a latest generation time of flight mass spectrometer in real time. Concerning the smoke evacuation device, the investigators will use the model IES 2 (Intelligent Evacuation System) from Erbe Swiss medical for this study.

Since this is only an observational study in which the investigators are only recording the type of surgery (i.e. open oder minimally invasive) and not recording sensitive patient data, the local ethics committee waived the need for an ethics committee approval of the study. In the end the smoke evacuation system does not have an effect on the patient or the procedure itself, but may rather influence the concentration of hazardous surgical fumes in the operating theatre.

Study Design

Study Type:
Observational
Actual Enrollment :
142 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Hazardous Surgical Smoke: Risk Assessment and Evaluation of a New Smoke Extractor System (SES) in the Surgical Unit
Actual Study Start Date :
May 13, 2019
Actual Primary Completion Date :
Sep 9, 2019
Actual Study Completion Date :
Sep 9, 2019

Arms and Interventions

Arm Intervention/Treatment
Minimally invasive surgery with smoke evacuation system (SES)

minimally invasive surgical procedures during which a smoke evacuation device is used

Device: Smoke evacuation system
The smoke evacuation system removes the surgical smoke directly near the electrocautery tip, where it is generated

Minimally invasive surgery without SES

minimally invasive surgical procedures during which no smoke evacuation device is used

Open surgery with SES

open surgical procedures during which a smoke evacuation device is used

Device: Smoke evacuation system
The smoke evacuation system removes the surgical smoke directly near the electrocautery tip, where it is generated

Open surgery without SES

open surgical procedures during which no smoke evacuation device is used

Outcome Measures

Primary Outcome Measures

  1. Hazardous fumes - specifically the concentration of Furfural, Benzene and Butadiene [assessment of measurement will start 4 months after the project is started and will take up to 12 weeks]

    Analysis of surgical fume with real-time time of flight mass spectrometry

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All surgical procedures with a planned duration of more than 1 hour
Exclusion Criteria:
  • Patients with a contraindication for electrocautery use

  • Patients with Pacemaker or implantable cardioverter-defibrillator (ICD)

  • Patients with an implanted neurostimulator device

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Bern Bern Switzerland 3010

Sponsors and Collaborators

  • University Hospital Inselspital, Berne
  • Tofwerk AG, Thun Switzerland (equipment, data analysis)
  • Lungenliga Bern (main funding)
  • Erbe Swiss AG (equipment)

Investigators

  • Principal Investigator: Gregor J Kocher, PD, MD, Division of Thoracic Surgery, University Hospital Bern, Switzerland

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT03924206
Other Study ID Numbers:
  • SurgicalSmoke1
First Posted:
Apr 23, 2019
Last Update Posted:
Oct 3, 2019
Last Verified:
Oct 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital Inselspital, Berne
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 3, 2019